OIP-4 Antibody / PRAME
Functions as a transcriptional repressor, inhibiting the signaling of retinoic acid through the retinoic acid receptors RARA, RARB and RARG. Prevents retinoic acid-induced cell proliferation arrest, differentiation and apoptosis. This gene encodes an antigen that is preferentially expressed in human melanomas and that is recognized by cytolytic T lymphocytes. It is not expressed in normal tissues, except testis. The encoded protein acts as a repressor of retinoic acid receptor, and likely confers a growth advantage to cancer cells via this function. Alternative splicing results in multiple transcript variants.
Product Specifications
CAS Number
9000-83-3
Specifications
Immunohistochemistry (FFPE) : 1-2 µg/mL for 30 min at RT
UniProt
P78395
Host
Rabbit
Reactivity
Human
Immunogen
A recombinant partial protein sequence (within amino acids 100-509) from the human protein was used as the immunogen for the OIP-4 antibody.
Clonality
Recombinant Monoclonal
Isotype
IgG κ
Clone
PRAME/6928R
Type
Recombinant
Applications
IHC-P
Purity
Protein A/G affinity
Format
Purified
Buffer
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide
Reconstitution
Aliquot the OIP-4 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitations
This OIP-4 antibody is available for research use only.
Storage Conditions
Aliquot the OIP-4 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
Formulation
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05% sodium azide
Applications Notes
Optimal dilution of the OIP-4 antibody should be determined by the researcher.
Location
Nucleus, Cytoplasm, Cell membrane
Image Legend
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human HIV TAT specific factor 1 (HTATSF1) activation kit by CRISPRa
Recombinant SARS-CoV Spike/RBD Protein (RBD, His Tag)
